On behalf of the Japanese Association of Cancer Immunology (JACI) and in collaboration with the Society for Immunotherapy of Cancer (SITC), we are proud to present the 1st International Symposium on Cancer Immunology and Immunotherapy, scheduled to take place on March 22-24, 2024, in Sapporo, Japan.
The three-day hybrid meeting will provide attendees with a multidisciplinary educational environment focused on next-generation cancer immunotherapy in basic and clinical immunology. The program will feature cutting-edge research presentations by experts from affiliated societies in the USA, Europe, and Japan ranging from topics such as lymphoid tissue (TLS) in the tumor microenvironment, T-cell and antibody engineering for immunotherapy, immuno-senescence in cancer immunity, and new modalities of cancer immunotherapy.
Target Audience: Basic and clinical investigators from academic institutions and industries, clinicians from hospitals, graduate students, and post-doctoral fellows who wish to learn more about current and future cancer immunotherapy
Featured SITC Speakers: